Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Other Non-Current Assets (2018 - 2025)

Entera Bio has reported Other Non-Current Assets over the past 8 years, most recently at $6000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets changed 0.0% year-over-year to $6000.0, compared with a TTM value of $6000.0 through Dec 2025, changed 0.0%, and an annual FY2025 reading of $6000.0, changed 0.0% over the prior year.
  • Other Non-Current Assets came in at $6000.0 for Q4 2025, down from $86000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $8.0 million in Q1 2025 to a low of $6000.0 in Q3 2022.
  • Median Other Non-Current Assets over the past 5 years was $6000.0 (2022), compared with a mean of $574526.3.
  • The sharpest move saw Other Non-Current Assets tumbled 99.29% in 2022, then soared 133233.33% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $46000.0 in 2021, then crashed by 86.96% to $6000.0 in 2022, then changed by 0.0% to $6000.0 in 2023, then changed by 0.0% to $6000.0 in 2024, then changed by 0.0% to $6000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Other Non-Current Assets are $6000.0 (Q4 2025), $86000.0 (Q3 2025), and $6000.0 (Q2 2025).